Total Payments
$21,677
2024 Payments
$4,297
Companies
53
Transactions
1,113
Medicare Patients
19,467
Medicare Billing
$2.0M
Payment Breakdown by Category
Food & Beverage$21,249 (98.0%)
Education$428.34 (2.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,249 | 1,105 | 98.0% |
| Education | $428.34 | 8 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $3,074 | 167 | $0 (2024) |
| Janssen Biotech, Inc. | $2,148 | 90 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,016 | 106 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,445 | 63 | $0 (2024) |
| Lilly USA, LLC | $1,382 | 62 | $0 (2024) |
| LEO Pharma Inc. | $1,132 | 59 | $0 (2024) |
| GENZYME CORPORATION | $1,091 | 39 | $0 (2024) |
| PFIZER INC. | $1,014 | 57 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $989.52 | 55 | $0 (2024) |
| Amgen Inc. | $899.49 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,297 | 192 | ABBVIE INC. ($705.27) |
| 2023 | $4,331 | 197 | Janssen Biotech, Inc. ($581.55) |
| 2022 | $3,187 | 163 | ABBVIE INC. ($604.30) |
| 2021 | $2,408 | 126 | AbbVie Inc. ($361.94) |
| 2020 | $2,091 | 111 | LEO Pharma Inc. ($196.83) |
| 2019 | $2,127 | 118 | AbbVie, Inc. ($403.58) |
| 2018 | $1,866 | 117 | AbbVie, Inc. ($229.44) |
| 2017 | $1,370 | 89 | Celgene Corporation ($175.90) |
All Payment Transactions
1,113 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.19 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $11.07 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: ANTIBIOTIC | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.21 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: Immunology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug), JUBLIA | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.79 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $5.57 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Almirall LLC | Klisyri (Drug) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: DERMATOLOGY | ||||||
| 11/19/2024 | Tempus AI, Inc | Merlin Test (Device) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Oncology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $6.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/15/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $19.90 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 4,970 | 9,549 | $1.4M | $491,990 |
| 2022 | 31 | 4,862 | 9,341 | $1.3M | $495,032 |
| 2021 | 30 | 4,649 | 8,918 | $1.3M | $474,831 |
| 2020 | 28 | 4,986 | 9,731 | $1.5M | $494,711 |
Total Patients
19,467
Total Services
37,539
Medicare Billing
$2.0M
Procedure Codes
121
All Medicare Procedures & Services
121 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 2,223 | 4,447 | $755,729 | $253,272 | 33.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 328 | 463 | $70,376 | $30,944 | 44.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 302 | 380 | $66,500 | $26,392 | 39.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 161 | 230 | $49,450 | $21,163 | 42.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 44 | 47 | $34,357 | $15,995 | 46.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 302 | 437 | $48,507 | $15,114 | 31.2% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 191 | 652 | $30,644 | $14,862 | 48.5% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 24 | 30 | $24,180 | $11,627 | 48.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 91 | 122 | $22,692 | $11,232 | 49.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 100 | 132 | $25,212 | $11,174 | 44.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 146 | 229 | $20,381 | $9,156 | 44.9% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 196 | 253 | $24,339 | $8,599 | 35.3% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 24 | 26 | $17,784 | $7,896 | 44.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 241 | 1,402 | $35,050 | $6,841 | 19.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 82 | 82 | $15,252 | $6,417 | 42.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 192 | 221 | $12,818 | $6,204 | 48.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 32 | 40 | $11,120 | $5,094 | 45.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $8,928 | $3,810 | 42.7% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 27 | 34 | $10,200 | $3,684 | 36.1% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 32 | $13,312 | $3,266 | 24.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2023 | 40 | 47 | $6,298 | $3,174 | 50.4% |
| 17272 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | Office | 2023 | 17 | 26 | $8,242 | $2,868 | 34.8% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 17 | 25 | $11,375 | $2,794 | 24.6% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 18 | 19 | $8,987 | $2,214 | 24.6% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 24 | 25 | $5,475 | $2,063 | 37.7% |
About Dr. Matthew Petitt, DO
Dr. Matthew Petitt, DO is a Dermatopathology healthcare provider based in Pasadena, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912101593.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Petitt, DO has received a total of $21,677 in payments from pharmaceutical and medical device companies, with $4,297 received in 2024. These payments were reported across 1,113 transactions from 53 companies. The most common payment nature is "Food and Beverage" ($21,249).
As a Medicare-enrolled provider, Petitt has provided services to 19,467 Medicare beneficiaries, totaling 37,539 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 121 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location Pasadena, TX
- Active Since 06/14/2007
- Last Updated 06/13/2022
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1912101593
Products in Payments
- DUPIXENT (Biological) $2,111
- TREMFYA (Drug) $1,870
- SKYRIZI (Biological) $1,369
- TALTZ (Drug) $1,321
- COSENTYX (Biological) $1,200
- Otezla (Drug) $774.41
- EUCRISA (Drug) $726.61
- RINVOQ (Biological) $673.25
- COSENTYX (Drug) $658.96
- Humira (Biological) $590.08
- ADBRY (Biological) $557.37
- ENSTILAR (Drug) $554.15
- OPZELURA (Drug) $502.35
- VTAMA (Drug) $447.26
- ILUMYA (Biological) $368.08
- Puraply (Medical Supply) $342.33
- HUMIRA (Biological) $321.64
- Cimzia (Drug) $305.26
- NUZYRA (Drug) $302.26
- DORYX (Drug) $284.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.